Rezultati - Mevlude Inanc

Efficacy and Tolerability of First-Line Anti-eGFR and Anti-VEGF Therapy in Elderly Patients with Ras-Wild Metastatic Colon Cancer od Ender Doğan, Sedat Tarık Fırat, Murat Eser, Oktay Bozkurt, Mevlüde İnanç, Metin Özkan

Polni tekst

The prognostic importance of the global immune-nutrition-information index (GINI) in patients with Ras wild type metastatic colorectal cancer od Oktay Bozkurt, Rıdvan Gönül, Bugra Umut Kaya, Gozde Erturk Zararsiz, Mevlüde İnanc, Metin Özkan

Polni tekst

Second Line Therapies After Tyrosine Kinase Inhibitory in Metastatic Renal Cell Carcinoma od Ender DOĞAN, Sedat Tarık FIRAT, Ahmet Kürşad DİŞLİ, Şafak YILDIRIM DİŞLİ, Oktay BOZKURT, Mevlüde İNANÇ, Metin ÖZKAN

Polni tekst

Prognostic role of prognostic nutritional index change in patients with extensive stage small cell lung cancer treated with platinum-based chemotherapy od İrfan Buğday, Mevlüde İnanç, Metin Özkan, Oktay Bozkurt, Ramazan Coşar, Sedat Tarık Fırat, Emel Mutlu, Murat Eser, Ahmet Kürşad Dişli, Muhammet Cengiz

Polni tekst

The effect of albumin to alkaline phosphatase ratio on survival in patients with metastatic bone sarcomas od Oktay Bozkurt, Murat Eser, Ahmet Kürşad Dişli, Muhammet Cengiz, İrfan Buğday, Ramazan Coşar, Sedat Tarık Fırat, Metin Ozkan, Mevlüde İnanç, Emel Mutlu

Polni tekst

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study od Hasan Çağrı Yıldırım, Emel Mutlu, Elvin Chalabiyev, Miraç Özen, Merve Keskinkılıç, Sercan Ön, Abdussamet Çelebi, Bengü Dursun, Ömer Acar, Seda Kahraman, Musa Barış Aykan, Ömür Kaman, Akif Doğan, Atike Pınar Erdoğan, Özde Melisa Celayir, Damla Günenç, Deniz Can Güven, İbrahim Vedat Bayoğlu, Tuğba Yavuzşen, İlhan Hacıbekiroğlu, Mevlüde İnanç, Saadettin Kılıçkap, Şuayib Yalçın, Sercan Aksoy

Polni tekst

The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer od Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz, Mevlude Inanc, Metin Ozkan, Emel Mutlu Ozkan, Deniz Can Guven, Mustafa Erman, Latif Karahan, Elif Sahin, Anıl Karakayali, Pervin Can Sanci, Umut Kefeli, Devrim Cabuk, Erdem Kolemen, Mehmet Mutlu Kidi, Sedat Biter, Tolga Koseci, Muslih Urun, Berrak Mermit Ercek, Duygu Bayir, Gözde Agdas, Teoman Sakalar, Nargiz Majidova, Sedat Yildiz, Hacer Demir, Cengiz Akosman, Mustafa Ersoy, Saadettin Kilickap, Erkam Kocaaslan, Ezgi Turkoğlu, Sedat Yildirim, Hayati Arvas, Havva Yesil Cinkir, Aslihan Ezgi Apaydin Rollas

Polni tekst

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients od Muhammet Cengiz, Oktay Bozkurt, Ayse Nuransoy Cengiz, Deniz Can Guven, Elif Sahin, Emel Mutlu Ozkan, Mustafa Ersoy, Ezgi Turkoğlu, Sedat Yildirim, Erdem Kolemen, Beyza Unlu, Hayati Arvas, Mehmet Mutlu Kidi, Sedat Biter, Latif Karahan, Mustafa Erman, Ismail Oguz Kara, Meltem Baykara, Pervin Can Sanci, Anıl Karakayali, Umut Kefeli, Devrim Cabuk, Saadettin Kilickap, Teoman Sakalar, Nargiz Majidova, Berrak Mermit Ercek, Muslih Urun, Gözde Agdas, Duygu Bayir, Cengiz Akosman, Erkam Kocaaslan, Havva Yesil Cinkir, Aslihan Ezgi Apaydin Rollas, Mevlude Inanc, Metin Ozkan

Polni tekst

Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab od Gözde Ağdaş, Duygu Bayir, Elif Şahin, Muhammet Cengiz, Deniz Can Güven, Mehmet Salim Demir, Ertuğrul Bayram, Duygu Özaşkın, Meltem Baykara, Oktay Bozkurt, Mevlüde İnanç, Metin Özkan, Ayşe Nuransoy Cengiz, Mustafa Erman, Umut Kefeli, Emel Mutlu Özkan, Erkam Kocaaslan, Devrim Çabuk, Saadettin Kiliçkap, Pervin Can Sanci, Muslih Urun, Teoman Sakalar, Cengiz Akosman, Erdem Kolemen, Ezgi Turkoğlu, Anıl Karakayali, Mustafa Ersoy, Sedat Yildirim, Latif Karahan, Hayati Arvas, Mehmet Mutlu Kidi, Sedat Biter, Berrak Mermit Ercek, Nargiz Majidova, Havva Yesil Cinkir, Aslihan Ezgi Apaydin Rollas, İbrahim Karadağ

Polni tekst

Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study od Taha Koray Sahin, Fatih Atalah, Bahadir Koylu, Ahmet Oruc, Aydin Acarbay, Akgun Karakok, Sevgi Dogan, Cevat Ilteris Kikili, Görkem Turhan, Gamze Emin, Selahattin Celik, Ilknur Deliktas Onur, Tuba Ugur Tuzcu, Sedat Biter, Safa Can Efil, Fadime Sinem Ardic, Azer Gokmen, Halil Goksel Guzel, Kadri Turan, Ahmet Kürsad Disli, Salih Tunbekici, Erdem Goker, Mevlude Inanc, Ozlem Ozdemir, Banu Ozturk, Muslih Urun, Hatime Arzu Yasar, Mehmet Ali Nahit Sendur, Ismail Oguz Kara, Osman Sutcuoglu, Ozturk Ates, Tulay Eren, Atila Yildirim, Saadettin Kilickap, Omer Dizdar, Fatma Alev Turker, Mustafa Erman, Mehmet Artac, Fatih Selcukbiricik, Sercan Aksoy, Deniz Can Guven

Polni tekst

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study od Mustafa Seyyar, Ali Kalem, Mürsel Sali, Berkan Karabuğa, Taha Koray Sahin, Ahmet Kürşad Dişli, Alper Türkel, Berkan Karadurmuş, Ece Şahin Hafızoğlu, Nilüfer Avcı, Irem Bilgetekin, Naziyet Köse Baytemur, Esma Uguztemur, Utku Oflazoğlu, Hasibe Bilge Gür, İlhan Hacıbekiroğlu, Aysun Fatma Akkuş, Sernaz Topaloğlu, Ayberk Bayramgil, Özgecan Dülgar Kaya, Melike Yazıcı, Teoman Şakalar, Seval Akay, Nargiz Majidova, Murad Guliyev, Özkan Alan, Serkan Gülcü, Tülay Eren, Gökşen İnanç İmamoğlu, Ali Kaan Güren, Osman Köstek, Ahmet Ünlü, Banu Ozturk, Esra Aydın, Shamkhal Safarov, Bekir Doğan, Mehmet Akif Tükenmez, Teyfik Demir, Elif Şahin, Engin Erdemoğlu, Fatma Keskin Uzundere, Osman Bütün, Bülent Karabulut, Mehmet Uzun, Tuba Baydaş, Elanur Karaman, Hacı Arak, Ferhat Ekinci, Musa Barış Aykan, İsmail Ertürk, Deniz Can Guven, Adem Deligönül, Cengiz Karaçin, Öztürk Ateş, Mevlüde İnanç, Havva Yeşil, Sercan Aksoy, Tolga Köşeci, İlker Nihat Ökten, Hasan Çağrı Yıldırım, Devrim Çabuk

Polni tekst